SUPERNUS PHARMACEUTICALS, INC. Interest Receivable, Current
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Interest Receivable, Current of $493.00 thousand as of 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Notes › and Others
us-gaap:InterestReceivableCurrent · last filed 2014-11-12
- 2014-09-30: Interest Receivable, Current $493.00K.
- 2014-06-30: Interest Receivable, Current $496.00K.
- 2014-03-31: Interest Receivable, Current $636.00K.
- 2013-12-31: Interest Receivable, Current $483.00K.
| Period end | Interest Receivable, Current |
|---|---|
| 2014-09-30 | $493.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $496.00K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $636.00K 10-Q · filed 2014-05-13 |
| 2013-12-31 | $483.00K 10-Q · filed 2014-11-12 |
| 2013-09-30 | $982.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $791.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $672.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $664.00K 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |